Multidrug- resistant tuberculosis treatment with linezolid-containing regimen

The following is a case of multidrug-resistant pulmonary tuberculosis [MDR-TB] that was treated successfully with a linezolid-containing regimen. It was found that linezolid is an efficient medicine for MDR-TB treatment with an acceptable side effect profile. Treatment was maintained for 18 months, and closely monitoring toxicities did not reveal evidence of any neurologic adverse effects. However, despite our expectation, thrombocytopenia was seen after 2 years follow-up